Detailed Narrative
Q3 FY26 Financial Performance Overview
Sharda Cropchem reported a robust Q3 FY26, with total revenues growing by 39% year-on-year to INR 1,289 crores, driven by a 14% overall volume growth. The company achieved its highest-ever annual PAT in 9M FY26, with Q3 PAT surging by 366% YoY to INR 145 crores. EBITDA for the quarter increased by 59% to INR 245.5 crores, resulting in an EBITDA margin of 19.1%.
Segmental and Geographical Performance
The Agrochemical business was a primary growth driver, expanding by 48% year-on-year to INR 1,141 crores in Q3 FY26. In contrast, the non-agrochemical business degrew by 8.1% to INR 148 crores. Geographically, Europe and Latin America showed strong volume growth, while the NAFTA region experienced a year-on-year decline, which management attributed to 'heavy unpredictable and unusual climate conditions'.
Margin Expansion and Cost Management
Gross margins expanded by 220 basis points to 34.9% in Q3 FY26, and by 500 basis points to 35% for 9M FY26, primarily due to stabilizing input costs. Management noted that while current pricing levels are still lower than pre-COVID, improved sourcing costs have led to better overall margins for the company. They expect gross margins to be sustainable at 35% or higher for FY27.
Product Registration and Future Growth Pipeline
The company continues to invest significantly in product registrations, holding 3,004 total registrations as of December 31, 2025, with an additional 1,076 applications globally in the approval stage. However, management emphasized the inherent uncertainties and variable timelines (1 to 7 years) in the registration process, making it difficult to predict when these will become active and contribute to revenues.
Capital Allocation and Shareholder Returns
Sharda Cropchem remains a net debt-free company, holding INR 826 crores in cash and liquid investments as of December 31, 2025. The Board declared an interim dividend of INR 6 per share. For capital expenditure, INR 399 crores was spent in 9M FY26, with a planned INR 500 crores for FY26 and a guidance of INR 450-500 crores for FY27, indicating continued investment in growth.
Outlook and Guidance
The company is confident in achieving a 15% volume growth for FY27 and expects total revenue growth of 15-20% for the same period. EBITDA margins are projected to be maintained in the 18-20% range for FY26. Management anticipates the growth momentum to continue into Q4 FY26 and remain strong through FY27, with Q4 historically being the strongest quarter.